Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age24-65
SponsorMassachusetts General Hospital

About this trial

The objective of this study protocol is to test whether intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen functional connectivity with a key region in emotion regulation (ER) neurocircuitry (anterior insula, AI) and improve performance on ER-related tasks in patients with bipolar disorder. Individual IPL sites for stimulation will be identified through baseline, pre-TMS functional magnetic resonance imaging (fMRI) scans. Patient-specific IPL subregions showing positive functional connectivity with the anterior insula and falling within the patient-specific frontoparietal control network will be used as individualized target sites for TMS stimulation. Patients will be randomized to receive 24 sessions of active versus sham iTBS to patient-specific IPL targets (6 sessions/day, 4 days, 43,200 pulses total). Post-iTBS resting-state and task-based fMRI scans will be acquired 3 days after the final day of iTBS administration (Day 4) following identical procedures as baseline. Effects of iTBS-TMS on ER will be evaluated by comparing pre-TMS versus post-TMS functional connectivity and behavior during performance on ER tasks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals of all genders

ages 24-65

Diagnostic Statistical Manual (DSM-5) defined diagnosis of bipolar I or II disorder (BD); assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.) version 7.0.2.

Current depressive episode, assessed using the Montgomery-Asberg Depression Rating Scale (MADRS) score ≥20,

Disqualifiers

current mania/hypomania assessed by the Young Mania Rating Scale (YMRS > 12)

rapid-cycling bipolar illness, defined as >4 episodes per year, indicating increased risk of switch to mania

current active suicidality (suicidal ideation with intent or plan), as assessed by a score >4 on the MADRS item #10

current substance use disorder for the past 6 months; substance use disorder in remission permitted

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcranial Magnetic Stimulation (TMS)

    Device

    Transcranial magnetic stimulation (TMS) is a non-invasive tool for modulating patterns of brain activation and circuit connectivity. It uses electromagnetic pulses to induce electric currents over the cortex that serve to depolarize or hyperpolarize neurons, thereby changing patterns of synaptic activity. This study uses intermittent theta burst stimulation (iTBS), an efficient TMS protocol that uses high frequency (50Hz) triplets of TMS given every 200 milliseconds (i.e. at 5 Hz).

  • Sham (placebo) TMS

    Device

    Sham stimulation works by blocking the magnetic field with an internal spacer on the sham side of the TMS coil, allowing the operator to place the coil surface against the scalp. A brief electric pulse calibrated to the stimulator output is delivered to the scalp simultaneous to the TMS pulse to mimic the scalp sensation during the sham condition. 75 Importantly, the electric pulse is calibrated to the stimulator output to ensure a realistic sham condition.

Treatment groups

136 Participants
are divided into 2 treatment groups
Group A: Active intermittent theta burst stimulation (iTBS)Experimental treatment 1 intervention
Group B: Sham intermittent theta burst stimulation (iTBS)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Correlated functional magnetic resonance imaging (fMRI) time series (functional connectivity)

Primary outcome will be changes in the correlated time series between brain regions (inferior parietal lobule and anterior insula) from baseline to post intervention

Time frame
Baseline, 1-3 days post 4-day intervention (up to 4 weeks post Baseline)

Secondary outcomes

1

Affective Multisource Interference Task

Secondary outcome will be changes in reaction time responses to an affective interference task

Time frame
Baseline, 1-3 days post 4-day intervention (up to 4 weeks post Baseline)
2

Balloon Analogue Risk Task

Secondary outcome will be changes in number of button presses in response to a risk versus reward task

Time frame
Baseline, 1-3 days post 4-day intervention (up to 4 weeks post Baseline)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Massachusetts General Hospital

Lead sponsor

University of Pennsylvania

Collaborator